Our research strengths include cancer genomics, DNA damage, RNA biology, and drug development. We are developing expertise in drug delivery, with a focus on nanotechnology-driven delivery of small RNA mimics and inhibitors.
Translating today's discoveries in childhood cancer research into tomorrow's treatments.
Greehey Children’s Cancer Research Institute is only one of two institutes in the United States dedicated solely to pediatric cancer research. Its 18 laboratories focus their strengths in cancer genomics, DNA repair, RNA biology, and drug development on finding new and less toxic treatments for childhood cancers.
Top stories
Symposium 2023 Announcements
News
Events
-
10X Genomics Day at UT Health San Antonio
Please join us to learn how single-cell, spatial, and in situ technologies from 10x Genomics can help you push the boundaries of your research. -
Greehey CCRI Seminar Series: Edward Seto, PhD – George Washington (in-person)
Presentation Title: Targeting HDACs for Cancer Therapy and Beyond. -
Greehey CCRI Seminar Series: Douglas Kojetin, PhD – UF Scripps Biomedical Research & Scripps Research (in-person)
Presentation title: "Nuclear receptor function made crystal clear with NMR spectroscopy."